NSCLC, cancer stem cells
Showing 1 - 25 of >10,000
MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC
Not yet recruiting
- Lung Neoplasms
- +2 more
- Tumor samples
-
Bordeaux, FranceCHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médic
Aug 28, 2023
Cancer Stem Cell Specific Aptamer's Ability to Detect Blood
Completed
- Pancreatic Neoplasm
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Feb 15, 2023
Cerebral Adrenoleukodystrophy Trial in Minneapolis (Mesenchymal stem cells (IV-MSC))
Recruiting
- Cerebral Adrenoleukodystrophy
- Mesenchymal stem cells (IV-MSC)
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Sep 7, 2023
Glioblastoma Trial in Rozzano (18F-GE-180 PET, Advanced MRI, Collection of hematopoietic stem cells)
Not yet recruiting
- Glioblastoma
- 18F-GE-180 PET
- +4 more
-
Rozzano, (mi), ItalyIRCCS Istituto Clinico Humanitas
Oct 27, 2023
Lymphoma Trial in Chongqing (PEG-rhG-CSF, RhG-CSF)
Recruiting
- Lymphoma
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Aug 31, 2023
MACSSI (MAstectomie Cellules Souches Surveillance Immunitaire)
Recruiting
- Breast Cancer
- Characterization of breast stem & immune system cells infiltrated in the mammary gland
-
Lyon, FranceCentre Léon Bérard
Aug 26, 2022
Ovarian Cancer Trial in Chongqing (Autologous blood transfusion with haematopoietic stem cells)
Recruiting
- Ovarian Cancer
- Autologous blood transfusion with haematopoietic stem cells
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
May 29, 2022
CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes
Recruiting
- Unresectable /Inoperable Locally Advanced (Stage II-III) Non-small Cells Lung Cancer (NSCLC)
-
Grozny, Russian Federation
- +4 more
May 31, 2023
Cervical Cancer Trial in Chongqing (Autologous blood transfusion with haematopoietic stem cells)
Recruiting
- Cervical Cancer
- Autologous blood transfusion with haematopoietic stem cells
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Sep 13, 2022
Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,
Not yet recruiting
- Acute Myeloid Leukemia
- +5 more
- Cytokine Induced Memory-like Natural Killer Cells
- Interleukin-2
-
Boston, Massachusetts
- +1 more
Nov 14, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia
Completed
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +14 more
- Aldesleukin
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Cancer of Breast Trial in San Antonio (Rapamycin)
Active, not recruiting
- Cancer of Breast
-
San Antonio, TexasUniversity of Texas Health Science Center San Antonio
Mar 6, 2022
Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, NSCLC Trial in United States (LYL797)
Recruiting
- Triple Negative Breast Cancer
- +14 more
- LYL797
-
Scottsdale, Arizona
- +10 more
Jan 30, 2023
Multiple Myeloma Trial in New York (drug, biological, procedure)
Active, not recruiting
- Multiple Myeloma
- busulfan
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 3, 2023
Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)
Active, not recruiting
- Plasma Cell Leukemia
- Plasma Cell Myeloma
- Autologous Hematopoietic Stem Cell Transplantation
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)
Recruiting
- Pancreatic Adenocarcinoma Metastatic
- +14 more
- Melphalan
- +5 more
-
Boston, Massachusetts
- +1 more
Dec 6, 2022
Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Cleveland
Not yet recruiting
- Allogeneic Stem Cell Transplant Candidate
- +4 more
- Cellular therapy product
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 1, 2022
Recurrent Glioblastoma Trial in Los Angeles (Activated T cells)
Not yet recruiting
- Recurrent Glioblastoma
- Activated T cells
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Apr 21, 2022
Cardiomyopathy, Heart Failure Trial in Houston (Laboratory Biomarker Analysis, Standard of Care, Mesenchymal Stem Cell
Completed
- Cardiomyopathy
- Heart Failure
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 11, 2022
Acute GVHD Trial in Kansas City (MSCTC-0010 Dose Escalation)
Recruiting
- Acute Graft Versus Host Disease
- MSCTC-0010 Dose Escalation
-
Kansas City, KansasKansas University Cancer Center
Jan 30, 2023
B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from
Recruiting
- B-Cell Lymphoid Malignancies
- +2 more
- Hematopoietic Stem Cells from HLA-compatible Related
- Hematopoietic Stem Cells from HLA Unrelated
-
Miami, FloridaMiami Cancer Institute at Baptist Health of South Florida
May 5, 2022
B-Cell Non-Hodgkin Lymphoma, DLBCL, Mantle Cell Lymphoma Trial in Duarte (Anti-CD19-CAR CMV-specific T-lymphocytes, Autologous
Not yet recruiting
- B-Cell Non-Hodgkin Lymphoma
- +7 more
- Anti-CD19-CAR CMV-specific T-lymphocytes
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 28, 2022
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- sargramostim
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 3, 2022
Circulating Tumor Cells In NSCLC Undergoing Definitive
Active, not recruiting
- Non-small Cell Lung Cancer
- Radiotherapy
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Mar 31, 2022
Lung Cancer, Non Small Cell Lung Cancer, Circulating Tumor Cell Trial (Endobronchial ultrasound)
Not yet recruiting
- Lung Cancer
- +2 more
- Endobronchial ultrasound
- (no location specified)
Sep 27, 2022